- Home
- APLM vs SMTK Comparison
APLM vs SMTK Comparison
Compare APLM & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- SMTK
- Stock Information
- Founded
- APLM 2016
- SMTK 2009
- Country
- APLM United States
- SMTK United Kingdom
- Employees
- APLM N/A
- SMTK N/A
- Industry
- APLM Blank Checks
- SMTK
- Sector
- APLM Finance
- SMTK
- Exchange
- APLM Nasdaq
- SMTK NYSE
- Market Cap
- APLM 6.9M
- SMTK 6.1M
- IPO Year
- APLM N/A
- SMTK N/A
- Fundamental
- Price
- APLM $6.14
- SMTK N/A
- Analyst Decision
- APLM
- SMTK
- Analyst Count
- APLM 0
- SMTK 0
- Target Price
- APLM N/A
- SMTK N/A
- AVG Volume (30 Days)
- APLM 7.8K
- SMTK 154.0K
- Earning Date
- APLM 08-13-2025
- SMTK 08-11-2025
- Dividend Yield
- APLM N/A
- SMTK N/A
- EPS Growth
- APLM N/A
- SMTK N/A
- EPS
- APLM N/A
- SMTK N/A
- Revenue
- APLM $198,000.00
- SMTK $105,000.00
- Revenue This Year
- APLM $415.15
- SMTK N/A
- Revenue Next Year
- APLM N/A
- SMTK N/A
- P/E Ratio
- APLM N/A
- SMTK N/A
- Revenue Growth
- APLM N/A
- SMTK 854.54
- 52 Week Low
- APLM $4.47
- SMTK $0.78
- 52 Week High
- APLM $35.98
- SMTK $7.80
- Technical
- Relative Strength Index (RSI)
- APLM 47.85
- SMTK N/A
- Support Level
- APLM $6.21
- SMTK N/A
- Resistance Level
- APLM $6.80
- SMTK N/A
- Average True Range (ATR)
- APLM 0.52
- SMTK 0.00
- MACD
- APLM 0.00
- SMTK 0.00
- Stochastic Oscillator
- APLM 51.61
- SMTK 0.00
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.